Latest News and Press Releases
Want to stay updated on the latest news?
-
Phase III RELAX-AHF-2 study did not meet primary endpoints of reduced cardiovascular death or worsening heart failure in patients with acute heart failure Novartis remains committed to...
-
Männedorf, Schweiz, 21. März 2017 - Die Tecan Group (SIX Swiss Exchange: TECN) gab heute die Veröffentlichung des Geschäftsberichts 2016 auf der Internetseite des Unternehmens www.tecan.com in der...
-
Männedorf, Switzerland, March 21, 2017 - The Tecan Group (SIX Swiss Exchange: TECN) today announced the publication of its 2016 Annual Report in the Investor Relations section of the company's...
-
New data suggests that disease modification with Cosentyx may be achievable for around 20% of patients following one year of treatment[1] Patients with longer disease duration before treatment...
-
Distribution increase to CHF 0.45 per share confirmed Integrated Report and Group's Consolidated Financial Statements for fiscal year 2016 approved Shareholders approve Compensation...
-
New post-hoc analysis of PARADIGM-HF data demonstrates Entresto lowered levels of HbA1c (a measure of glycemic control) by 0.26% vs. 0.16% for ACE-inhibitor enalapril in heart failure with reduced...
-
Clariant to be listed among the 20 highest-yielding stocks in the SPI index Positive result of meeting target to increase or at...
-
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Sika AG hat heute, nach Publikation der...
-
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Today after the publication of the invitation...
-
ALLSCHWIL/BASEL, SCHWEIZ - 15. März 2017 - Actelion Ltd (SIX: ATLN) veröffentlichte heute im Namen des Verwaltungsrats die offizielle Einladung zur diesjährigen ordentlichen Generalversammlung. Die...